Sokichi Honda

机构：Astellas Pharma (Japan), Astellas Pharma (China), Astellas Pharma (Germany)

发表论文 29 篇 · 总被引 364 次 · h-index 12

代表论文

• Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome (2020 · Scientific Reports · 被引 54)
• Auditory Steady State Response; nature and utility as a translational science tool (2019 · Scientific Reports · 被引 52)
• The centrally acting non-narcotic antitussive tipepidine produces antidepressant-like effect in the forced swimming test in rats (2009 · Behavioural Brain Research · 被引 30)
• Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers (2023 · Schizophrenia Research · 被引 26)
• A Novel Antidepressant-like Action of Drugs Possessing GIRK Channel Blocking Action in Rats (2010 · YAKUGAKU ZASSHI · 被引 24)
• The potent inhibitory effect of tipepidine on marble-burying behavior in mice (2010 · Behavioural Brain Research · 被引 20)